Palatin Technologies Inc. (PTN:NASDAQ) closed at $5.51 on October 22, 2026, down 0.72% on the day. The stock trades 82.2% below its 52-week high of $31.00 and 2.0% above its 52-week low of $5.40. Over the past year, it lost 74.0%. Palatin Technologies Inc. is part of the Health Care sector.
In 219 trading sessions since December 9, 2025, PTN closed higher on 92 days (42%). Its best day was December 9, 2025 (+28.62%) and its worst was September 15, 2026 (-18.11%). The stock moved 10% or more in a single session 22 times. It opened at least 5% above the previous day's high 1 time.
Palatin is a biopharmaceutical company developing medicines that target the melanocortin receptor system with targeted, receptor-specific product candidates for the treatment of diseases with significant unmet medical need and commercial potential. Palatin's strategy is to develop products and then form collaborations with industry leaders to maximize their commercial potential.
Find more stocks like PTN with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.